| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-06 | 2025-03-13 | 2024-03-12 | 2023-03-06 | 2022-03-15 | 2020-12-31 | 2019-12-31 |
| Revenue | 0.674 | 0.636 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0.065 | 0 | 0.15 | 0.167 | 0.109 | 0.062 | 0.026 |
| Gross Profit | 0.644 | 0.636 | -0.15 | -0.167 | -0.109 | -0.062 | -0.026 |
| Operating Expenses | 38.9 | 61.13 | 78.78 | 67.72 | 45.54 | 25.24 | 17.62 |
| Research & Development | 23.3 | 41.51 | 53.54 | 40.69 | 26.91 | 17.63 | 11.37 |
| Selling, General and Administrative | 15.61 | 19.62 | 25.39 | 27.2 | 18.74 | 7.67 | 6.28 |
| Other Operating Expenses | 0 | 0 | -0.15 | -0.167 | -0.109 | -0.062 | -0.026 |
| Operating Income | -38.26 | -60.5 | -78.93 | -67.88 | -45.65 | -25.3 | -17.64 |
| Net Non-Operating Interest | 2.44 | 4.22 | 6.15 | 1.96 | 0.044 | 0.122 | 0.158 |
| Interest Income | 2.44 | 4.22 | 6.15 | 1.96 | 0.054 | 0.171 | 0.197 |
| Interest Expense | 0 | 0 | 0 | 0 | 0.01 | 0.049 | 0.039 |
| Equity & Other Income/(Expense) | 21.65 | -1.5 | -1.78 | -1.81 | -1.41 | -1.28 | 0.024 |
| Income Before Tax | -14.17 | -57.77 | -74.56 | -67.73 | -47.01 | -26.46 | -17.46 |
| Income Tax Expense | 0 | 0 | 0 | -1.07 | 0 | -0.015 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0.166 |
| Net Income | -14.17 | -57.77 | -74.56 | -66.65 | -47.01 | -26.45 | -17.63 |
| Depreciation and Amortization | 0.119 | 0.131 | 0.15 | 0.167 | 0.109 | 0.062 | 0.026 |
| EBITDA | -38.14 | -60.37 | -78.78 | -67.72 | -45.54 | -25.24 | -17.62 |
| Earnings Per Share (EPS) | -2.6 | -10.64 | -14.72 | -16.72 | -11.68 | -9.52 | -4.4 |
| Diluted Earnings Per Share | -2.6 | -10.64 | -14.72 | -16.72 | -11.68 | -9.52 | -6.32 |
| Weighted Average Shares Outstanding | 5.63 | 5.44 | 5.06 | 3.98 | 4.02 | 2.78 | 2.78 |
| Diluted Weighted Average Shares Outstanding | 5.63 | 5.44 | 5.06 | 3.98 | 4.02 | 2.78 | 2.78 |
